Page 133 - 中国全科医学2022-20
P. 133

·2562· http://www.chinagp.net   E-mail:zgqkyx@chinagp.net.cn


               Facial emotion recognition in Parkinson's disease:an fMRI   Curr Neuropharmacol,2020,18(4):277-287. DOI:10.2174/
               investigation[J]. PLoS One,2015,10(8):e0136110.      1570159X17666191016094857.
               DOI:10.1371/journal.pone.0136110.               [39]BOLOGNA M,PAPARELLA G. Pathophysiology of rigidity
           [29]MURRAY R J,BROSCH T,SANDER D. The functional profile   in  Parkinson's  disease:another  step  forward[J].  Clin
               of the human amygdala in affective processing:insights from   Neurophysiol,2020,131(8):1971-1972. DOI:10.1016/j.
               intracranial recordings[J]. Cortex,2014,60:10-33. DOI:  clinph.2020.05.013.
               10.1016/j.cortex.2014.06.010.                   [40]SU G,LIN B,YIN J,et al. Detection of hypomimia in patients
           [30]PÉRON  J,FRÜHHOLZ  S,VÉRIN  M,et  al.  Subthalamic   with Parkinson's disease via smile videos[J]. Ann Transl Med,
               nucleus:a key structure for emotional component synchronization   2021,9(16):1307. DOI:10.21037/atm-21-3457.
               in humans[J]. Neurosci Biobehav Rev,2013,37(3):358-  [41]ALI M R,MYERS T,WAGNER E,et al. Facial expressions
               373. DOI:10.1016/j.neubiorev.2013.01.001.            can detect Parkinson's disease:preliminary evidence from videos
           [31]MAYCAS-CEPEDA T,LOPEZ-RUIZ P,FELIZ-FELIZ C,et al.    collected online[J]. NPJ Digit Med,2021,4(1):129.
               Hypomimia in Parkinson's disease:what is it telling us?[J]. Front   DOI:10.1038/s41746-021-00502-8.
               Neurol,2020,11:603582. DOI:10.3389/fneur.2020.603582.  [42]AVNER A,STEVEN G,CAMILLA K,et al. Automated computer
                                                                    vision assessment of hypomimia in Parkinson disease:proof-of-
           [32]MATTAVELLI  G,BARVAS  E,LONGO  C,et  al.  Facial
                                                                    principle pilot study[J]. Journal of Medical Internet Research,
               expressions  recognition  and  discrimination  in  Parkinson's
                                                                    2021,23(2):e21037. DOI:10.2196/21037.
               disease[J]. J Neuropsychol,2021,15(1):46-68. DOI:
                                                               [43]ELENA P,DANIELE V,ALBERTO C,et al. Quantitative
               10.1111/jnp.12209.
                                                                    evaluation of hypomimia in parkinson's disease:a face tracking
           [33]DAN R,RUZICKA F,BEZDICEK O,et al. Impact of dopamine
                                                                    approach[J].  Sensors,2022,22(4):1358.  DOI:
               and cognitive impairment on neural reactivity to facial emotion in
                                                                    10.3390/s22041358.
               Parkinson's disease[J]. Eur Neuropsychopharmacol,2019,29(11):
                                                               [44]STROTZER Q D,ANTHOFER J M,FALTERMEIER R,et al.
               1258-1272. DOI:10.1016/j.euroneuro.2019.09.003
                                                                    Deep brain stimulation:connectivity profile for bradykinesia
           [34]RICCIARDI L,VISCO-COMANDINI F,ERRO R,et al. Facial
                                                                    alleviation[J]. Ann Neurol,2019,85(6):852-864. DOI:
               emotion recognition and expression in Parkinson's disease:an
                                                                    10.1002/ana.25475.
               emotional mirror mechanism?[J]. PLoS One,2017,12(1):
                                                               [45]WAGENBRETH C,KUEHNE M,HEINZE H J,et al. Deep brain
               e0169110. DOI:10.1371/journal.pone.0169110.
                                                                    stimulation of the subthalamic nucleus influences facial emotion
           [35]RICCIARDI L,BOLOGNA M,MORGANTE F,et al. Reduced
                                                                    recognition in patients with Parkinson's disease:a review[J].
               facial expressiveness in Parkinson's disease:a pure motor
                                                                    Front Psychol,2019,10:2638. DOI:10.3389/fpsyg.2019.02638.
               disorder?[J]. J Neurol Sci,2015,358(1-2):125-130.
                                                               [46]MARNEWECK M,HAMMOND G. Voluntary control of facial
               DOI:10.1016/j.jns.2015.08.1516.
                                                                    musculature in Parkinson's disease[J]. J Neurol Sci,2014,347
           [36]GASCA-SALAS C,URSO D. Association between hypomimia
                                                                    (1-2):332-336. DOI:10.1016/j.jns.2014.11.003.
               and mild cognitive impairment in de novo Parkinson's disease
                                                               [47]RICCIARDI L,BAGGIO P,RICCIARDI D,et al. Rehabilitation
               patients[J]. Can J Neurol Sci,2020,47(6):855-857.
                                                                    of hypomimia in Parkinson's disease:a feasibility study of two
               DOI:10.1017/cjn.2020.93.
                                                                    different approaches[J]. Neurol Sci,2016,37(3):431-
           [37]PAGONABARRAGA  J,KULISEVSKY  J,STRAFELLA  A
                                                                    436. DOI:10.1007/s10072-015-2421-9.
               P,et al. Apathy in Parkinson's disease:clinical features,
                                                               [48]DUMER AI,OSTER H,MCCABE D,et al. Effects of the Lee
               neural substrates,diagnosis,and treatment[J]. The Lancet
                                                                    Silverman Voice Treatment(LSVT® LOUD) on hypomimia in
               Neurology,2015,14(5):518-531. DOI:10.1016/S1474-
                                                                    Parkinson's disease[J]. J Int Neuropsychol Soc,2014,20(3):
               4422(15)00019-8.                                     302-312. DOI:10.1017/S1355617714000046.
           [38]ASSOGNA F,PELLICANO C,SAVINI C,et al. Drug choices and     (收稿日期:2022-02-05;修回日期:2022-04-10)
               advancements for managing depression in Parkinson's disease[J].                 (本文编辑:赵跃翠)
   128   129   130   131   132   133